A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-26
DOI
10.1038/s41598-017-02821-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Infliximab quantitation in human plasma by liquid chromatography-tandem mass spectrometry: towards a standardization of the methods?
- (2016) Jean-Francois Jourdil et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- RAS Mutations as Predictive Biomarkers in Clinical Management of Metastatic Colorectal Cancer
- (2016) Paul Waring et al. Clinical Colorectal Cancer
- EGFR monoclonal antibodies in locally advanced head and neck squamous cell carcinoma: What is their current role?
- (2016) Mohamed Alorabi et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Quantification of active infliximab in human serum with liquid chromatography–tandem mass spectrometry using a tumor necrosis factor alpha -based pre-analytical sample purification and a stable isotopic labeled infliximab bio-similar as internal standard: A target-based, sensitive and cost-effective method
- (2016) Mohsin El Amrani et al. JOURNAL OF CHROMATOGRAPHY A
- Development and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies
- (2016) Inmaculada Suárez et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Unknown
- (2016) Proteomics Clinical Applications
- Cetuximab pharmacokinetics influences overall survival in head and neck cancer patients
- (2016) Yoann Pointreau et al. THERAPEUTIC DRUG MONITORING
- Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques
- (2015) Mark Spengler et al. ANALYST
- Multiplex Quantification of Protein Toxins in Human Biofluids and Food Matrices Using Immunoextraction and High-Resolution Targeted Mass Spectrometry
- (2015) Mathieu Dupré et al. ANALYTICAL CHEMISTRY
- First-Line Treatment of Metastatic Colorectal Cancer: Interpreting FIRE-3, PEAK, and CALGB/SWOG 80405
- (2015) Elena Elez et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma
- (2015) Susan E. Abbatiello et al. MOLECULAR & CELLULAR PROTEOMICS
- Influence ofFCGRTgene polymorphisms on pharmacokinetics of therapeutic antibodies
- (2013) Christophe Passot et al. mAbs
- Personalized medicine in oncology: where have we come from and where are we going?
- (2013) Fabrice André et al. PHARMACOGENOMICS
- Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
- (2012) Paola Picotti et al. NATURE METHODS
- Genetic Polymorphisms of FcγRIIa and FcγRIIIa Are Not Predictive of Clinical Outcomes after Cetuximab plus Irinotecan Chemotherapy in Patients with Metastatic Colorectal Cancer
- (2012) Seong Joon Park et al. ONCOLOGY
- Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum
- (2012) T. Shi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PASSEL: The PeptideAtlas SRMexperiment library
- (2012) Terry Farrah et al. PROTEOMICS
- Cetuximab Pharmacokinetics Influences Progression-Free Survival of Metastatic Colorectal Cancer Patients
- (2011) N. Azzopardi et al. CLINICAL CANCER RESEARCH
- Pellet digestion: a simple and efficient sample preparation technique for LC–MS/MS quantification of large therapeutic proteins in plasma
- (2011) Zheng Ouyang et al. Bioanalysis
- DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity
- (2010) Chen Guang Yang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- All about KRAS for clinical oncology practice: Gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer
- (2010) Helena Linardou et al. CANCER TREATMENT REVIEWS
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
- (2009) Terri A Addona et al. NATURE BIOTECHNOLOGY
- Immunopurification and Mass Spectrometric Quantification of the Active Form of a Chimeric Therapeutic Antibody in Human Serum
- (2008) Mathieu Dubois et al. ANALYTICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search